Cannabis for asthma & COPD: vaporizers instead of smoking
- THC has bronchodilatory effect via CB1 – but ONLY when not smoked
- Cannabis smoking: contraindicated in asthma and COPD – smoke exacerbates inflammation and obstruction
- Vaporizer (170°C): the only sensible form of inhalation for lung diseases – no combustion products
Cannabis for lung diseases: The dilemma
Asthma and COPD (chronic obstructive pulmonary disease) are the most common respiratory diseases in Germany. Smoking cannabis is contraindicated for both diseases – the smoke exacerbates inflammation and bronchospasms. At the same time, studies show that cannabinoids (especially CBD and THC) can have anti-inflammatory and bronchodilatory properties via the ECS. The form of consumption decides everything.
Asthma: What the research shows
Asthma is an inflammatory airway disease with reversible obstruction. CB1 and CB2 receptors are found in bronchial epithelial cells and mast cells – the cells that are activated during an asthma attack.
| Study | Design | Result |
|---|---|---|
| Tashkin et al. 1975 (Am Rev Respir Dis) | RCT, asthma patients, THC inhaled vs. salbutamol | Smoke form: bronchospasm possible; THC as aerosol: bronchodilation comparable to salbutamol for ~1h |
| Ribeiro & Bhaskaran 2020 (Eur Respir J) | Review, ECS and airways | CB1/CB2 in airways; ECS activation reduces mast cell degranulation and histamine release; CB2 anti-inflammatory |
| Vuolo et al. 2019 (Eur J Pharmacol) | Animal model, CBD + asthma mouse model | CBD significantly reduces airway infiltration, cytokine levels (IL-4, IL-13, TNF-α) and mucosal changes |
What this means: THC as an aerosol (not smoked!) shows bronchodilation – but no modern clinical studies prove its use as an asthma treatment. CBD shows strong anti-inflammatory effect on airways in animal models. Smoking is absolutely contraindicated for asthma patients.
COPD: More complex situation
COPD is irreversibly progressive (unlike asthma) with structural lung remodeling. Specific cannabis-COPD data are limited:
Positive:
– Cannabis smoking shows less COPD progression than tobacco with the same consumption in some studies – THC/CBD possibly protective against emphysema via CB2 modulation
– Pain and dyspnea (shortness of breath) in advanced COPD: cannabis as a palliative option, exclusively via vaporizer or orally
Negative:
– Acute cannabis smoking increases mucus production and cough in COPD
– No known COPD regression effect – cannabis does not slow down lung degradation
– Inhalation risk even with vaporizer in very severe COPD (FEV1 <30 %)
Vaporizers: The decisive difference
For asthma and COPD patients who want to use cannabis medicinally, the vaporizer is the only acceptable inhalation route:
– Temperature 170-200°C – no combustion, no tar, no PAHs
– CO release minimal (Zuurman 2008, J Psychopharmacol)
– Onset of action within 1-5 minutes (important for acute pain)
– Approved medical devices: Volcano Medic 2 (Storz & Bickel), Mighty Medic
For severe COPD (FEV1 <50 %): oil or capsule instead of any inhalation.
CBD for asthma: mechanism and practice
CBD has multiple anti-inflammatory effects on the respiratory tract:
– Inhibits mast cell activation (IgE-mediated)
– Reduces Th2 cytokine release (IL-4, IL-13 = key mediators in allergic asthma)
– TRPV1 desensitization can reduce dry cough
– Anxiolysis: anxiety can trigger or exacerbate asthma attacks; CBD anxiolysis breaks this cycle
Practical for asthma patients: CBD oil 25-50 mg daily as inflammation modulation – in addition to existing inhalation therapy (corticoids, beta-2 agonists). Not a substitute for emergency sprays.
GKV: Cannabis for COPD and asthma
Cannabis on prescription is unlikely for asthma or COPD alone. Reimbursable concomitant indications:
– Chronic pain (in advanced COPD with thoracic pain)
– Severe sleep disorders
– Palliative care (dyspnea in the terminal phase)
- Smoking cannabis: Lung risks
Comparison of forms of consumption
FAQ: Cannabis for asthma and COPD
Summary
Cannabis smoking is absolutely contraindicated in asthma and COPD. Cannabinoids themselves have anti-inflammatory effects on airways: CBD reduces Th2 cytokines and mast cell activation in animal models; THC as aerosol showed bronchodilation in early RCTs. For patients with medical indication: vaporizer only (170-200°C) or oral ingestion. Cannabis and lungs explains the general smoking risks; always check interactions with asthma medication (corticoids, beta-2 agonists) with a doctor.
Cannabis for Crohn's disease: CBD, remission & studies
Cannabis for restless legs: CBD, dopamine & studies
Cannabis & bones: CB2, osteoporosis & bone healing
Cannabis & testosterone: effect on male fertility
Cannabis quality: laboratory tests, pesticides & contamination
Home cannabis cultivation: rules according to CanG
